This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Health Winners & Losers

Among the winners in the health sector Tuesday was Angiotech Pharmaceuticals (ANPI), shares of which rose about 12%. The Vancouver-based drug and medical-device company, which last week halted patient enrollment in a study of its Vascular Wrap for artery disease due to safety issues, said Tuesday it is exploring "alternatives for the future funding and development" of the product, including potential partnerships. The company posted an adjusted net loss from continuing operations of $3.9 million, or 5 cents a share, in the first quarter. The stock, which took a hard hit last week, climbed 34 cents, or 12.8%, to $2.99.

Another win came courtesy of Hanger Orthopedic Group (HGR - Get Report), shares of which climbed more than 8% on quarterly results and forward guidance. The Bethesda-based company, which distributes orthotic and prosthetic devices and operates related care centers, posted first-quarter net income of $3.6 million, or 12 cents a share, double the $1.8 million, or 6 cents a share, it posted a year ago. Hanger increased its full-year EPS guidance by a nickel to a range of 75 cents to 77 cents in light of more favorable interest rates. The stock traded up 8.7% to $11.58.
This article was written by a staff member of
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
HGR $6.90 0.00%
IDIX $24.50 0.20%
BIIB $263.12 0.00%
MRK $54.81 0.00%
THC $31.46 0.00%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs